Small molecule inhibitor compounds for inhibiting Rac1 activity and their use for treating, preventing, or reducing the incidences of malignant and nonmalignant manifestations, e.g., plexiform neurofibromas that occur in subjects suffering from neurofibromatosis type 1 (NF1) are disclosed.
本研究公开了用于抑制 Rac1 活性的小分子
抑制剂化合物及其在治疗、预防或降低恶性和非恶性表现(如神经纤维瘤病 1 型(NF1)患者发生的丛状神经纤维瘤)的发病率方面的用途。